CTKB — CYTEK BIOSCIENCE

Ownership history in MARSHALL WACE, LLP  ·  5 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in CYTEK BIOSCIENCE (CTKB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 134,286 -127,066 -48.6% 0.00% $466K $3.47
2025 Q2 ADDED 261,352 +192,761 +281.0% 0.00% $889K $3.40
2024 Q1 ADDED 68,591 +14,495 +26.8% 0.00% $460K $6.71
2022 Q2 ADDED 54,096 +46,936 +655.5% 0.00% $582K $10.73
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CTKB price (monthly, adj. close)

Other funds also holding CTKB

As of 2025 Q4 — sorted by position size

Topline Capital Management, LLC 3.4% HHLR ADVISORS, LTD. 3Y 7Y 1.08% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 0.86% Numerai GP LLC 3Y 0.11% ROYCE & ASSOCIATES LP 3Y 7Y 0.09% Dynamic Technology Lab Private Ltd 3Y 7Y 0.05% PDT Partners, LLC 3Y 7Y 0.03% Boston Partners 3Y 7Y 0.03% AXQ CAPITAL, LP 3Y 0.02% MILLENNIUM MANAGEMENT LLC 3Y 7Y 0.01%
← Back to MARSHALL WACE, LLP Holdings